Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis
Open Access
- 6 September 2019
- journal article
- review article
- Published by Springer Nature in Clinical Epigenetics
- Vol. 11 (1) , 1-12
Abstract
Chronic pancreatitis presents a high risk of inflammation-related progression to pancreatic cancer. Pancreatic cancer is the fourth leading cause of cancer-related death worldwide. The high mortality rate is directly related to the difficulty in promptly diagnosing the disease, which often presents as overt and advanced. Hence, early diagnosis for pancreatic cancer becomes crucial, propelling research into the molecular and epigenetic landscape of the disease. Recent studies have shown that cell-free DNA methylation profiles from inflammatory diseases or cancer can vary, thus opening a new venue for the development of biomarkers for early diagnosis. In particular, cell-free DNA methylation could be employed in the identification of pre-neoplastic signatures in individuals with suspected pancreatic conditions, representing a specific and non-invasive method of early diagnosis of pancreatic cancer. In this review, we describe the molecular determinants of pancreatic cancer and how these are related to chronic pancreatitis. We will then present an overview of differential methylated genes in the two conditions, highlighting their diagnostic or prognostic potential. Exploiting the relation between abnormally methylated cell-free DNA and pre-neoplastic lesions or chronic pancreatitis may become a game-changing approach for the development of tools for the early diagnosis of pancreatic cancer.Keywords
Funding Information
- FFABR (000020_FFABR_2017_ANGRISANO.TIZIANA)
This publication has 86 references indexed in Scilit:
- MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3PLOS ONE, 2013
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- The ARF Tumor Suppressor Inhibits Tumor Cell Colonization Independent of p53 in a Novel Mouse Model of Pancreatic Ductal Adenocarcinoma MetastasisMolecular Cancer Research, 2011
- Genome-Wide Analysis of Promoter Methylation Associated with Gene Expression Profile in Pancreatic AdenocarcinomaClinical Cancer Research, 2011
- Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced SenescenceCancer Cell, 2011
- Distant metastasis occurs late during the genetic evolution of pancreatic cancerNature, 2010
- Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detectionBest Practice & Research Clinical Gastroenterology, 2010
- Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor modelNature Biotechnology, 2010
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- Array-Based Multiplex Analysis of DNA Methylation in Breast Cancer TissuesThe Journal of Molecular Diagnostics, 2008